• This Site
  • All C&T Science Resources
Wordpress Facebook You Tube Twitter

RFA: Strategic Pharma-Academic Research Consortium (SPARC) Awards

RFA: Strategic Pharma-Academic Research Consortium (SPARC) Awards

The Midwest Strategic Pharma-Academic Research Consortium (SPARC) awards program has released an RFA to support pharmaceutical related projects in the non-competitive intellectual property space. Letters of intent are due March 18, 2016.

Projects to be considered may include a focus on, but are not limited to, early translational medicine and potential identification of therapeutic targets in the area of human Autoimmune Diseases with the following goals:

  • To improve the definition of autoimmune diseases (in particular, to move towards molecular classification rather than clinically-defined syndromes) and to devise biomarkers that will predict response to therapy and enable early monitoring of the response to therapy. Studies that include longitudinal sample collection from well-characterized patients are particularly encouraged.
  • To increase patient-focused research to understand mechanisms driving chronic inflammatory disease in order to improve and tailor therapies.

Download the RFA for more information

Submit an application

Eligibility Criteria Important Dates
  • download the attached PDF
Letter of Intent Deadline 03/18/2016 Application Deadline 06/17/2016 Anticipated Start Date 09/01/2016
Related Pages

Clinical Research Collaborative Networks
Funding Opportunities
Acknowledging CTSA grant support in publications

Back to Top New Information

See Older News
Close